Fast-Growing Oncology Startup OncoLens Secures $7.25 Million Series A Funding
2021-01-14
OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced today that it has raised a $7.25 million Series A investment from BIP Capital, Martin Ventures, and SeedToB Capita...
NCI designated VCU Massey Cancer Center signs with OncoLens
2021-01-05
Massey Cancer Center, an NCI designated cancer institute, has a strong focus on advancing clinical research and care collaboration within the Virginia community. OncoLens is proud to announce that VCU...
Inova Schar Cancer Institute to utilize OncoLens for care treatment planning at its tumor boards
2020-12-15
Inova Schar Cancer has chosen the OncoLens platform as a tool to streamline their tumor boards or multi-disciplinary cancer conferences, but more importantly align care among their seven hospitals. I...
